赛通姆治疗

最新新闻

• 评级变动
  Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/3/19
• 评级变动
  Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/5/13
• 评级变动
  Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $15
  \u5e02\u573a\u8d44\u8baf · 2026/3/18
• 评级变动
  Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/3/23
• 评级变动
  Wolfe Research Initiates CytomX(CTMX.US) With Buy Rating, Announces Target Price $6
  \u5e02\u573a\u8d44\u8baf · 2026/5/19
• Piper Sandler Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $12
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  H.C. Wainwright Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11
  \u5e02\u573a\u8d44\u8baf · 2026/5/11
• J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $15
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• Barclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  Oppenheimer Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2026/2/6
• J.P. Morgan Maintains CytomX(CTMX.US) With Buy Rating, Cuts Target Price to $11
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Jefferies Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/3/18
• 评级变动
  Barclays Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2026/2/4
• 评级变动
  A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $11 to $16
  \u5e02\u573a\u8d44\u8baf · 2026/5/9
• Wedbush Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/6/4
• 评级变动
  Cantor Fitzgerald Maintains CytomX(CTMX.US) With Buy Rating, Raises Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2026/3/9
• 评级变动
  Guggenheim Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $10
  \u5e02\u573a\u8d44\u8baf · 2026/3/9
• 评级变动
  A Quick Look at Today's Ratings for CytomX(CTMX.US), With a Forecast Between $10 to $17
  \u5e02\u573a\u8d44\u8baf · 2026/3/17

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。